$2.27
-0.13-5.42%
Last update: Oct 22, 7:12 PM
Quantum BioPharma Ltd (QNTM) Stock Price, Quote, News & History
QNTMNASDAQ
Quantum BioPharma signed an agreement with Thermo Fisher to initiate a Phase 2 clinical trial for its multiple sclerosis therapy, Lucid-MS.
You can purchase shares of Quantum BioPharma (NASDAQ:QNTM) through any online brokerage.
Other companies in Quantum BioPharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Quantum BioPharma has a consensus price target of $8.00.
The stock price for Quantum BioPharma (NASDAQ: QNTM) is $2.25 last updated October 22, 2026 at 7:12 PM EDT.
There are no upcoming dividends for Quantum BioPharma.
Quantum BioPharma does not have any upcoming earnings scheduled.
There is no upcoming split for Quantum BioPharma.
Quantum BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug...
